AMGN AMGEN INC

2026Q1 · CUSIP 031162100 · Big Pharma · Sector: Healthcare & Biotech

Lit · Institutions accelerating in

Holders

3,120

Δ holders QoQ

+37

Breadth percentile

Top 7%

Whale holders

333

Δ whales

-6

Inst. holding value

$147.8B

New positions

227

Closed positions

190

Price momentum (1Q)

-12.5%

Put / Call

41/46

Breadth history (34 quarters)

Period	Percentile	Next-1Q return	Next-2Q return
2026Q1	Top 7%	—	—
2025Q4	Top 1%	-12.5%	—
2025Q1	Top 1%	+7.1%	+24.9%
2024Q4	Top 17%	-5.0%	+1.8%
2024Q3	Top 6%	+9.6%	-0.8%
2024Q2	Top 1%	-7.9%	-7.0%
2023Q4	Top 1%	+10.9%	+17.2%
2023Q3	Top 0%	+6.2%	+18.7%
2022Q4	Top 1%	-3.4%	+13.8%
2022Q2	Top 4%	+13.6%	-2.9%
2022Q1	Top 3%	+2.9%	+16.5%
2021Q4	Top 2%	+10.4%	+13.9%
2020Q4	Top 5%	+9.2%	+0.7%
2020Q3	Top 5%	-1.0%	+6.6%
2020Q2	Top 3%	-1.7%	-1.7%
2019Q4	Top 1%	+5.9%	+11.1%
2019Q3	Top 5%	+1.4%	+4.7%
2018Q4	Top 1%	-9.2%	+11.9%
2018Q3	Top 6%	-3.7%	-10.3%
2018Q2	Top 14%	-3.1%	-3.4%
2018Q1	Top 17%	+13.2%	+9.7%

Show all 21 events

Put holders

QoQ: -7

Call holders

QoQ: -5

See methodology →

PE (TTM)

24.8

EPS (TTM)

$14.37

EPS YoY

+31.0%

Revenue (TTM)

$37.2B

Revenue YoY

+9.1%

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)